10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $857,051 | -16.4% | 20,777 | +13.2% | 0.00% | -20.0% |
| Q2 2023 | $1,025,111 | +15.1% | 18,358 | +15.0% | 0.01% | +25.0% |
| Q1 2023 | $890,799 | +53.3% | 15,967 | +0.1% | 0.00% | +33.3% |
| Q4 2022 | $581,218 | +46.8% | 15,950 | +14.8% | 0.00% | +50.0% |
| Q3 2022 | $396,000 | -37.9% | 13,890 | -1.6% | 0.00% | -50.0% |
| Q2 2022 | $638,000 | -44.3% | 14,110 | -6.3% | 0.00% | -33.3% |
| Q1 2022 | $1,145,000 | -42.3% | 15,051 | +13.0% | 0.01% | -40.0% |
| Q4 2021 | $1,984,000 | +2.5% | 13,319 | +0.1% | 0.01% | 0.0% |
| Q3 2021 | $1,936,000 | -33.4% | 13,301 | -10.4% | 0.01% | -37.5% |
| Q2 2021 | $2,906,000 | -38.9% | 14,839 | -43.5% | 0.02% | -42.9% |
| Q1 2021 | $4,757,000 | +6.0% | 26,282 | -17.0% | 0.03% | +3.7% |
| Q4 2020 | $4,486,000 | – | 31,684 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |